Creative Medical Technology Holdings, Inc.
CELZ
$2.21
-$0.07-3.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 75.95% | 6.19% | |||
| Depreciation & Amortization | -0.64% | 1.30% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 53.09% | 0.75% | |||
| Operating Income | -52.85% | -0.75% | |||
| Income Before Tax | -52.74% | -0.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -52.74% | -0.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -52.74% | -0.21% | |||
| EBIT | -52.85% | -0.75% | |||
| EBITDA | -54.17% | -0.75% | |||
| EPS Basic | -46.84% | -0.21% | |||
| Normalized Basic EPS | -46.84% | -0.20% | |||
| EPS Diluted | -46.84% | -0.21% | |||
| Normalized Diluted EPS | -46.84% | -0.20% | |||
| Average Basic Shares Outstanding | 4.02% | 0.00% | |||
| Average Diluted Shares Outstanding | 4.02% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||